Metropolitan Life Insurance CO Kezar Life Sciences, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.13 - $7.31 $882 - $2,061	-282 Reduced 8.85%	2,903 $9,000
Q4 2022 Jun 14, 2023	BUY	$6.39 - $8.8 $1,801 - $2,481	282 Added 9.71%	3,185 $22.4 Million
Q3 2022 Jun 14, 2023	BUY	$7.99 - $10.75 $2,253 - $3,031	282 Added 9.71%	3,185 $27.4 Million
Q3 2022 Mar 30, 2023	BUY	$7.99 - $10.75 $6,160 - $8,288	771 Added 31.94%	3,185 $27,000
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $6,160 - $8,288	771 Added 31.94%	3,185 $27,000
Q2 2022 Jun 20, 2023	SELL	$4.58 - $17.13 $2,239 - $8,376	-489 Reduced 16.84%	2,414 $19,000
Q1 2022 Jun 20, 2023	SELL	$12.3 - $18.33 $6,014 - $8,963	-489 Reduced 16.84%	2,414 $40,000
Q1 2022 Mar 30, 2023	SELL	$12.3 - $18.33 $88,596 - $132,030	-7,203 Reduced 74.9%	2,414 $40,000
Q1 2022 May 12, 2022	SELL	$12.3 - $18.33 $88,596 - $132,030	-7,203 Reduced 74.9%	2,414 $40,000
Q4 2021 Jun 21, 2023	BUY	$7.44 - $16.72 $49,952 - $112,258	6,714 Added 231.28%	9,617 $160,000
Q4 2021 Mar 30, 2023	SELL	$7.44 - $16.72 $1,264 - $2,842	-170 Reduced 1.74%	9,617 $160,000
Q4 2021 Feb 15, 2022	SELL	$7.44 - $16.72 $1,264 - $2,842	-170 Reduced 1.74%	9,617 $161,000
Q3 2021 Jun 21, 2023	BUY	$4.85 - $9.73 $33,387 - $66,981	6,884 Added 237.13%	9,787 $84,000
Q3 2021 Mar 30, 2023	BUY	$4.85 - $9.73 $23,119 - $46,382	4,767 Added 94.96%	9,787 $84,000
Q3 2021 Nov 15, 2021	BUY	$4.85 - $9.73 $47,466 - $95,227	9,787 New	9,787 $85,000
Q2 2019 Jul 12, 2023	BUY	$7.09 - $21.9 $15,009 - $46,362	2,117 Added 72.92%	5,020 $38.7 Million
Q2 2019 Aug 14, 2019	SELL	$7.09 - $21.9 $35,591 - $109,938	-5,020 Closed	0 $0
Q1 2019 Jul 13, 2023	BUY	$16.83 - $23.75 $35,629 - $50,278	2,117 Added 72.92%	5,020 $89,000
Q1 2019 Mar 30, 2023	BUY	$16.83 - $23.75 $30,883 - $43,581	1,835 Added 57.61%	5,020 $89,000
Q1 2019 May 16, 2019	BUY	$16.83 - $23.75 $28,897 - $40,778	1,717 Added 51.98%	5,020 $89,000
Q1 2019 May 15, 2019	BUY	$16.83 - $23.75 $55,589 - $78,446	3,303 New	3,303 $117,000

Others Institutions Holding KZR

# of Institutions

Shares Held

36.1M

Call Options Held

13.8K

Put Options Held

600

Suvretta Capital Management, LLC New York, NY

7.17M
Shares

$44.6 Million
0.22% of portfolio
Avidity Partners Management LP Dallas, TX

5.03M
Shares

$31.3 Million
0.24% of portfolio
Tang Capital Management LLC San Diego, CA

3.64M
Shares

$22.6 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.74M
Shares

$17 Million
0.0% of portfolio
Affinity Asset Advisors, LLC New York, NY

2.51M
Shares

$15.6 Million
0.33% of portfolio

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $425M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account